Novo Nordisk A/S (NVO) reported second-quarter 2024 earnings of 65 cents per American Depositary Receipt (ADR), which missed the Zacks Consensus Estimate of 71 cents. The company had reported earnings of 63 cents per ADR in the year-ago quarter.Revenues of $9.82 billion increased 25% in both Danish kroner (DKK) and at constant exchange rate (CER) in the reported quarter. However, total revenues missed the Zacks Consensus Estimate of $9.91 billion. The year-over-year increase in revenues was driven by higher ...